newsfilter
← Latest News
GlobeNewswire·

BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates

- $243.7 million in total second quarter revenues, primarily comprised of $222.4 million of U.S. Attruby® net product revenue, with growth led by the treatment-naïve segment as physicians increasingly start and keep